Trois-Rivières / San Francisco / Edmonton / Moncton / Winnipeg / Montreal / Ottawa / Halifax / Vancouver / Toronto / Saskatoon / London / /
Company
National Microbiology Laboratory / /
Country
Canada / / /
Facility
Health Sciences Centre / University of Manitoba / Mount Sinai Hospital / Children's Hospital of Eastern Ontario / Montreal General Hospital / University of Alberta Hospital / Ottawa Hospital / Royal Victoria Hospital / Royal University Hospital / Vancouver Hospital / J. A. KARLOWSKY1 / 2 University of Manitoba1 / Michael's Hospital / London Health Sciences Centre / /
Royal Victoria Hospital / Children's Hospital of Eastern Ontario / Health Sciences Centre / East Regional Health Authority / University of Manitoba / University of Alberta / F. SCHWEIZER1 / D. J. HOBAN1 / 2 and J. A. KARLOWSKY1 / 2 University of Manitoba1 / Health Sciences Centre2 / and St. Boniface Hospital3 / Canadian Antimicrobial Resistance Alliance / Department of Clinical Microbiology / Montreal General Hospital / Ottawa Hospital / Royal University Hospital / St. Michael's Hospital / Alberta Hospital / Vancouver Hospital / Mount Sinai Hospital / /
Person
R. Davidson / L. Matukas / J. Fuller / Z. Hussain / G. Zhanel / J. Blondeau / M. Desjardins / F. Chan / Elizabeth II / D. Hoban / M. Kuhn / D. Roscoe / V. Loo / M. Goyette / G. G. Zhanel / / /
E – 779 In Vitro Activity of Plazomicin Against Gram-Negative and Gram-Positive Pathogens Isolated from Patients in Canadian Hospitals in 2011: CANWARD Surveillance Study Dr. G. G. Zhanel Health Sciences Centre